Clinical Trials Directory

Trials / Completed

CompletedNCT03416920

A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
167 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
21 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to evaluate Wellframe, a patient engagement platform that includes a mobile phone application for patients, for its impact on supporting patients who have undergone a percutaneous coronary intervention. The patient mobile app has articles about cardiovascular disease and other health related topics, patient-reported outcomes surveys, physical activity tracking, reminders for medications and upcoming appointments, and two-way communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages patients to achieve their health goals and stay engaged in their health. The feasibility of onboarding patients to the app and the clinical efficacy of the platform will be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERWellframeWellframe mobile phone app

Timeline

Start date
2018-02-12
Primary completion
2019-08-20
Completion
2019-08-20
First posted
2018-01-31
Last updated
2023-07-17
Results posted
2023-07-17

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03416920. Inclusion in this directory is not an endorsement.